AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 28698186
Drug: Insulin:glucose molar
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Insulin:glucose molar ratio
Trial: 23404232
Drug: Standard regadenoson
RxNorm normalized name: Regadenoson
DrugBank: Regadenoson (DB06213)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Standard regadenoson injection at rest
Trial: 2953501
Drug: Sufentanil bolus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil bolus 0.1 microgram X kg‐1 followed by continuous sufentanil infusion of 0‐7 micrograms X min‐1
Trial: 2953501
Drug: Fentanyl bolus
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Fentanyl bolus 0.7 microgram X kg‐1 followed by continuous fentanyl infusion of 0‐50 micrograms X min‐1
Trial: 29655134
Drug: Usual Care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual Care (UC) including pharmacotherapy and counseling sessions
Trial: 15142001
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of creatine (20 g per day for 6 days) and sodium bicarbonate (0.3 g per kg body weight 2 hours before swims)
Trial: 15142001
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of creatine and sodium bicarbonate
Trial: 11676942
Drug: Adjunctive PCI
RxNorm normalized name: PCI-27483
DrugBank: PCI-27483 (DB13000)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjunctive PCI (TIMI 2 or 3 flow at 90 minutes)
Trial: 9570429
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) tablet
Trial: 9570429
Drug: Isosorbide dinitrate
RxNorm normalized name: Isosorbide Dinitrate
DrugBank: Isosorbide dinitrate (DB00883)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Isosorbide dinitrate (ISDN) spray
Trial: 9570429
Drug: Nitroglycerin (NTG)
DrugBank: Nitroglycerin (DB00727)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nitroglycerin (NTG) spray
Trial: 2438638
Drug: IM or
RxNorm normalized name: Betim Oral Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IM or oral iron treatments
Trial: 25176223
Drug: Myocet (M)
RxNorm normalized name: Coenzyme M
DrugBank: Coenzyme M (DB09110)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myocet (M) 60 mg/m2 i.v. plus cyclophosphamide (C) 600 mg/m2 on Day 1 of a 21‐day cycle (Arm A)
Trial: 25176223
Drug: Myocet (M)
RxNorm normalized name: Coenzyme M
DrugBank: Coenzyme M (DB09110)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Myocet (M) 50 mg/m2 plus vinorelbine (V) 25 mg/m2 i.v. on Day 1 and V 60 mg/m2 orally on Day 8 on a 21‐day cycle (Arm B)
Trial: 17426001
Drug: Postoperative intravenous
RxNorm normalized name: povidone-iodine
DrugBank: Povidone-iodine (DB06812)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Postoperative intravenous analgesia
Trial: 16279895
Drug: Photodynamic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Photodynamic therapy (PDT) with 2 mg/kg body weight of Photosan-3, light activation performed 48 hours after intravenous application
Trial: 9208360
Drug: Generic verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Generic verapamil (120 mg twice daily for 14 days)
Trial: 9208360
Drug: Brand-name verapamil
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brand-name verapamil (120 mg twice daily for 14 days)
Trial: 31990936
Drug: Anagliptin (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anagliptin (200 mg twice daily)
Trial: 31990936
Drug: Control (previous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (previous treatment schedules)
Trial: 27096722
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate 250‐μg metered‐dose inhaler
Trial: 27096722
Drug: Saline placebo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline placebo metered‐dose inhaler
Trial: 24196464
Drug: One-to-one therapy
RxNorm normalized name: Gel-One
FDA approved: no
EMA approved: no
PMDA approved: no
Description: One-to-one therapy
Trial: 24196464
Drug: Group-based therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group-based therapy
Trial: 19506003
Drug: Cardiac rehabilitation
RxNorm normalized name: Leonurus cardiaca extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cardiac rehabilitation with controlled breathing (6 breaths/min for 10 minutes twice daily during the eight-week treatment period)
Trial: 15277159
Drug: High zinc
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High zinc intake (12 mg/d)
Trial: 15277159
Drug: Low zinc
RxNorm normalized name: insulin low zinc
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low zinc intake (4 mg/d)
Trial: 10930963
Drug: Budesonide (BUD)
RxNorm normalized name: Budesonide
DrugBank: Budesonide (DB01222)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Budesonide (BUD) 1600 microg twice daily
Trial: 10930963
Drug: Fluticasone propionate
RxNorm normalized name: Fluticasone Propionate
DrugBank: Fluticasone propionate (DB00588)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Fluticasone propionate (FP) 1000 microg twice daily
Trial: 9024229
Drug: recombinant DNA‐derived
FDA approved: no
EMA approved: no
PMDA approved: no
Description: recombinant DNA‐derived preparations of human GH
Trial: 30782712
Drug: Acupuncture intervention
RxNorm normalized name: hydroquinone
DrugBank: Hydroquinone (DB09526)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acupuncture intervention (one treatment for five consecutive weeks)
Trial: 30782712
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (treatment offered after 6 weeks)
Trial: 25216762
Drug: Lapatinib and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lapatinib and capecitabine (L-CAP)
Trial: 19921305
Drug: Cognitive Behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioural Therapy (CBT), 10 sessions
Trial: 18844819
Drug: Sleep therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sleep therapy (multi-component intervention including sleep restriction, cognitive behavioral therapy, bright-light therapy, structured physical activity, and body temperature manipulations)
Trial: 12874586
Drug: Gelatine-coated Dacron
RxNorm normalized name: simethicone
DrugBank: Simethicone (DB09512)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gelatine-coated Dacron (GEL-D) grafts
Trial: 10583440
Drug: Inhaled nitric
RxNorm normalized name: nitric oxide Inhalant Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled nitric oxide (30 ppm, 30 min)
Trial: 10583440
Drug: Aspirin (640
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin (640 mg x 1 orally)
Trial: 8913542
Drug: Losartan 200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 200 mg
Trial: 8913542
Drug: Losartan 100
RxNorm normalized name: LOSARTAN 100MG TAB
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan 100 mg (multiple dosing)
Trial: 8913542
Drug: Placebo (multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (multiple dosing)
Trial: 7965263
Drug: Losartan (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Losartan (all doses)
Trial: 16837887
Drug: Oral conjugated
RxNorm normalized name: Conjugated Estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oral conjugated equine estrogens (CEE)
Trial: 6613808
Drug: Verapamil, 320
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Verapamil, 320 mg per day
Trial: 26866518
Drug: Secukinumab (300,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Secukinumab (300, 150 mg)
Trial: 25529851
Drug: Intramuscular dexmedetomidine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular dexmedetomidine (1 µg·kg‐1)
Trial: 25529851
Drug: Midazolam (0.02
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midazolam (0.02 mg·kg‐1)
Trial: 15084616
Drug: Gemcitabine +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine + Tipifarnib (200 mg bid orally continuously; gemcitabine at 1,000 mg/m² intravenously weekly x 7 for 8 weeks, then weekly x 3 every 4 weeks)
Trial: 15084616
Drug: Gemcitabine +
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gemcitabine + Placebo (gemcitabine at 1,000 mg/m² intravenously weekly x 7 for 8 weeks, then weekly x 3 every 4 weeks)
Trial: 2722598
Drug: Fluosol-DA 20%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluosol-DA 20% infusion (8 mL/Kg, 6 infusions) + 100% oxygen breathing
Trial: 2722598
Drug: Fluosol-DA 20%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluosol-DA 20% infusion (various dosages and infusions) + 100% oxygen breathing
Trial: 2722598
Drug: Fluosol-DA 20%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluosol-DA 20% infusion
Trial: 28595464
Drug: Baroreflex activation
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Baroreflex activation therapy (BAT) for 16 months
Trial: 28595464
Drug: Continuous pharmacotherapy
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous pharmacotherapy (BAT off) for 8 months followed by BAT for 8 months
Trial: 25281894
Drug: Inhaled budesonide
RxNorm normalized name: budesonide Inhalation Suspension
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inhaled budesonide (3 mg Bid)
Trial: 25281894
Drug: Systemic methylprednisolone
RxNorm normalized name: Methylprednisolone
DrugBank: Methylprednisolone (DB00959)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Systemic methylprednisolone (40 mg Qd for three days, then 8 mg Bid)
Trial: 21442135
Drug: Weekly 1‐hr
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly 1‐hr training session including aerobic interval training, circuit training, and whole body vibration
Trial: 10999783
Drug: Low isoflavone
RxNorm normalized name: low-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low isoflavone diet (1.00 mg/kg body wt/day, averaging 65 mg/day)
Trial: 10999783
Drug: High isoflavone
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High isoflavone diet (2.01 mg/kg body wt/day, averaging 130 mg/day)
Trial: 10999783
Drug: Control diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control diet (0.13 mg/kg body wt/day, averaging 8 mg/day)
Trial: 8852910
Drug: Interferon alpha-2b
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alpha-2b alone (10 million units/m2, three times weekly for 1 year)
Trial: 8852910
Drug: Interferon alpha-2b
RxNorm normalized name: Interferon alpha-2B
DrugBank: Interferon alfa-2b (DB00105)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Interferon alpha-2b after prednisone priming (10 million units/m2, three times weekly for 1 year)
Trial: 8852910
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no treatment, n=9)
Trial: 23758485
Drug: Eslicarbazepine acetate
RxNorm normalized name: Eslicarbazepine Acetate
DrugBank: Eslicarbazepine (DB14575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eslicarbazepine acetate once-daily (QD; 900 mg)
Trial: 23758485
Drug: Eslicarbazepine acetate
RxNorm normalized name: Eslicarbazepine Acetate
DrugBank: Eslicarbazepine (DB14575)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Eslicarbazepine acetate twice-daily (BID; 450 mg)
Trial: 23758485
Drug: Oxcarbazepine BID
RxNorm normalized name: Oxcarbazepine
DrugBank: Oxcarbazepine (DB00776)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Oxcarbazepine BID (450 mg)
Trial: 19897177
Drug: Oxytocin nasal
RxNorm normalized name: oxytocin Nasal Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxytocin nasal spray (18 or 24 IU)
Trial: 14967872
Drug: Carbohydrate meal
RxNorm normalized name: bone meal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate meal (C; 3 g carbohydrate/kg)
Trial: 14967872
Drug: Isoenergetic fat
RxNorm normalized name: Hard fat
DrugBank: Hard fat (DB11578)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isoenergetic fat meal (F; 1.3 g fat/kg)
Trial: 9085972
Drug: Intravenous lidocaine
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous lidocaine with propofol
Trial: 9085972
Drug: Topical nitroglycerin
RxNorm normalized name: nitroglycerin Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nitroglycerin ointment with plain propofol
Trial: 9085972
Drug: Topical nitroglycerin
RxNorm normalized name: nitroglycerin Topical Ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical nitroglycerin ointment with propofol mixed with lidocaine
Trial: 8458683
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg, product A)
Trial: 8458683
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg, product B)
Trial: 30439316
Drug: Progressive early
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Progressive early bed physical activity (15-30 minutes, twice a day)
Trial: 30439316
Drug: Intermittent pneumatic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent pneumatic compression (IPC) (30 minutes, twice a day)
Trial: 18345549
Drug: Subcutaneous injection
RxNorm normalized name: EPINEPHRINE 0.3 mg SUBCUTANEOUS INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous injection of physiological saline (placebo)
Trial: 16943455
Drug: Vitamin E
RxNorm normalized name: Vitamin E
DrugBank: Vitamin E (DB00163)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Vitamin E (50 mg/day)
Trial: 14689793
Drug: Mairin-P (isoniazid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mairin-P (isoniazid 60 mg, rifampicin 120 mg, pyrazinamide 300 mg, ethambutol hydrochloride 225 mg)
Trial: 14689793
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment regimens with antituberculous drugs
Trial: 3100871
Drug: Flutamide +
RxNorm normalized name: Flutamide
DrugBank: Flutamide (DB00499)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Flutamide + LHRH agonist [D‐Trp6]LHRH ethylamide
Trial: 3100871
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy (Flutamide + LHRH agonist)
Trial: 22071882
Drug: Fingolimod 0.5
RxNorm normalized name: fingolimod 0.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fingolimod 0.5 mg and 1.25 mg
Trial: 15896421
Drug: Enteral solution
RxNorm normalized name: GASTROENTERAL SOLUTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enteral solution of arginine
Trial: 15896421
Drug: Control solution
RxNorm normalized name: Nausea Control Solution
DrugBank: Chloroxylenol (DB11121)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control solution of amino-acids
Trial: 11447774
Drug: Occlusive calcipotriol
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Occlusive calcipotriol 50 micrograms/mg ointment applied twice-weekly overnight under occlusion
Trial: 11447774
Drug: Nonocclusive calcipotriol
RxNorm normalized name: calcipotriol
DrugBank: Calcipotriol (DB02300)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonocclusive calcipotriol 50 micrograms/mg ointment applied twice-daily
Trial: 9746766
Drug: Low-dose 6-methylprednisolone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose 6-methylprednisolone (6MPred; 2 mg/kg/d; n = 47)
Trial: 9746766
Drug: High-dose 6-methylprednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose 6-methylprednisolone (6MPred; 10 mg/kg/d; n = 48)
Trial: 9746766
Drug: Low-dose 6-methylprednisolone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose 6-methylprednisolone (6MPred; 2 mg/kg/d; switched to high-dose after 5 days)
Trial: 9746766
Drug: Low-dose 6-methylprednisolone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose 6-methylprednisolone (6MPred; 2 mg/kg/d; continued with tapering doses)
Trial: 3167248
Drug: Conjoint Therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conjoint Therapy (8 sessions)
Trial: 18849028
Drug: L-arginine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine (20 mg/min) and tetrahydrobiopterin (BH(4)) (500 microg/min)
Trial: 18849028
Drug: L-arginine and
RxNorm normalized name: Amino Acid, Amino Acids 5% (L-Arginine and L-Lysine) intravenous solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-arginine and BH(4) infusion
Trial: 16202894
Drug: Heparin-bonded cardiopulmonary
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Heparin-bonded cardiopulmonary bypass circuits (HBCPB)
Trial: 12376201
Drug: Anastrozole alone
RxNorm normalized name: Anastrozole
DrugBank: Anastrozole (DB01217)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Anastrozole alone or in combination with tamoxifen
Trial: 10411413
Drug: Spironolactone 100
RxNorm normalized name: spironolactone 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Spironolactone 100 mg/day with an oral contraceptive
Trial: 10411413
Drug: Cyproterone acetate
RxNorm normalized name: cyproterone acetate
DrugBank: Cyproterone acetate (DB04839)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyproterone acetate 50 mg/day on days 1 to 10 with an oral contraceptive
Trial: 10411413
Drug: Flutamide 250
RxNorm normalized name: flutamide 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide 250 mg twice a day
Trial: 2185691
Drug: Ciprofloxacin (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (750 mg every 12 h)
Trial: 2185691
Drug: Ciprofloxacin (750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ciprofloxacin (750 mg every 12 h) and oral rifampin (300 mg every 12 h)
Trial: 84900
Drug: 3% acycloguanosine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3% acycloguanosine eye ointment
Trial: 84900
Drug: Topical acycloguanosine
RxNorm normalized name: Acycloguanosine
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Topical acycloguanosine alone
Trial: 26345602
Drug: ALA (600 mg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ALA (600 mg qd)
Trial: 21250901
Drug: MVM+D (multivitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MVM+D (multivitamin and mineral supplement plus vitamin D 1,200 IU/day)
Trial: 21250901
Drug: MVM (multivitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MVM (multivitamin and mineral supplement)
Trial: 19625236
Drug: Orally administered
RxNorm normalized name: no vaccine administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Orally administered antidiabetic drugs (OADs) combination therapies
Trial: 19625236
Drug: Single-tablet OAD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single-tablet OAD combinations
Trial: 7978472
Drug: Ropivacaine (0.25%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ropivacaine (0.25% plain solution, 140 mg, 56 ml)
Trial: 7978472
Drug: Bupivacaine (0.25%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bupivacaine (0.25% plain solution, 140 mg, 56 ml)
Trial: 30835573
Drug: Intralesional injection
RxNorm normalized name: DEXAMETHASONE SODIUM PHOSPHATE 4 mg in 1 mL INTRALESIONAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional injection of bevacizumab
Trial: 30835573
Drug: Intralesional injection
RxNorm normalized name: DEXAMETHASONE SODIUM PHOSPHATE 4 mg in 1 mL INTRALESIONAL INJECTION
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralesional injection of triamcinolone acetonide (TAC)
Trial: 31313296
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg once daily with water
Trial: 31313296
Drug: Omeprazole 40
RxNorm normalized name: omeprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole 40 mg with 250 mL of Coca-Cola
Trial: 31313296
Drug: Sofosbuvir/velpatasvir (SOF/VEL)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sofosbuvir/velpatasvir (SOF/VEL) 400/100 mg alone (reference)
Trial: 23393319
Drug: In-center daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: In-center daily hemodialysis (6 days per week)
Trial: 23393319
Drug: Daily hemodialysis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily hemodialysis (6 days per week)
Trial: 18359280
Drug: 250 mg
RxNorm normalized name: rutin 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 250 mg dose of methylprednisolone (Group I)
Trial: 18359280
Drug: 500 mg
RxNorm normalized name: bran 500 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 500 mg dose of methylprednisolone (Group II)
Trial: 18359280
Drug: four 250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: four 250 mg doses of methylprednisolone (Group III)
Trial: 18359280
Drug: four 500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: four 500 mg doses of methylprednisolone (Group IV)
Trial: 17324243
Drug: Desloratadine syrup
RxNorm normalized name: Desloratadine
DrugBank: Desloratadine (DB00967)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Desloratadine syrup 0.625 mg (1.25 ml) for children aged > or =6 months to <1 year